Cornerstone Investors — How Anchor Money Gets Locked Into an IPO
How cornerstone investors like Nvidia and Eli Lilly pre-commit IPO capital before pricing, what the lock-up requires, and why it's not free for the issuer.
The commitment that happens before the roadshow starts
Most institutional demand for an IPO shows up during book-building — the week or two before pricing when the underwriters take orders from mutual funds, hedge funds, and other buyers. A cornerstone investment is different: it's negotiated and signed before the prospectus is even public, for a fixed dollar amount, at (or near) the eventual offer price. The investor isn't guessing at demand — they've already agreed to buy in, and the company discloses that commitment to every other buyer who reads the filing.
That distinction matters because it changes what the number means. When a filing says a company has "strong anchor demand," that can mean anything. When it says a specific, named investor has committed a specific, disclosed sum ahead of the roadshow, that's a fact other investors can underwrite their own decision against — which is exactly why issuers seek cornerstones out for their largest, highest-scrutiny deals. The IPO pipeline tracked in the app currently has several live examples of exactly this structure.
What makes it "cornerstone" and not just a big order
The mechanics, per market practice built out mostly in Hong Kong and European IPOs and increasingly borrowed by U.S. deals:
- Binding, pre-prospectus agreement. The investor signs a placing letter before the deal is marketed, committing to a fixed amount regardless of where the book eventually prices.
- Guaranteed allocation. In exchange for locking in early, the cornerstone is guaranteed the shares — no risk of getting scaled back the way a late order in a hot book might be.
- A lock-up. Cornerstones can't flip the position. Hong Kong deals typically require a six-month hold; other markets vary, but the lock-up is the point — it's what turns "I said I'd buy" into "I can't sell even if I wanted to," and that's the signal other investors are actually pricing in.
- Disclosure. The identity and size of the commitment go into the prospectus by name. This is the opposite of an anonymous large order — it's meant to be seen.
An "anchor investor" is a related but looser term — in Indian IPOs specifically it refers to institutions allocated shares a day ahead of the public offer, with a much shorter lock-in (30 days for half the shares, 90 for the rest) and less negotiating leverage than a true cornerstone. The words get used loosely in press coverage, but the lock-up length is the tell for which one you're actually looking at.
The precedent: Arm's ten cornerstones
The clearest recent U.S. example predates this year's IPO wave. When Arm Holdings went public on Nasdaq in 2023, ten strategic partners — including Nvidia, Apple, Google, and several of Arm's own chip-industry customers — signed up as cornerstone investors for a combined roughly $735 million, buying at the IPO price alongside everyone else. The deal wasn't really about the money; Arm didn't need $735 million to fund the business. It was about signaling that the companies who depend on Arm's technology most were willing to put a locked-up, disclosed number behind that dependency.
Why the 2026 pipeline is full of the same structure
That Arm playbook is now showing up repeatedly, and Nvidia is the most frequent signatory. In Anthropic's planned listing — still tracking toward a roughly $2 trillion valuation and a $100 billion-plus raise — Nvidia has been reported to be weighing a cornerstone stake of up to $10 billion, which would be by far the largest such commitment on record and would follow the up-to-$10 billion compute-linked investment Nvidia already agreed to in November 2025.
SB Energy's S-1 shows the same instinct in a different form: Nvidia committed $1.5 billion in a private placement at the IPO price, then added a second $1.5 billion prepaid forward contract — prepaying now for shares to be delivered later at 90% of the IPO price — bringing its total commitment to $3 billion ahead of a listing SB Energy is targeting near a $50 billion valuation.
Biotech IPOs run a related version through "directed share" commitments rather than formal cornerstone placements. TRex Bio's S-1 discloses that Eli Lilly — already a collaboration partner worth over $1.1 billion in potential milestones — has indicated it may buy shares in the offering up to a combined 19.9% ownership stake with its existing holdings. Lilly's letter is explicitly non-binding, which is the key difference from a true cornerstone: the company can walk from that number, while a signed Hong Kong-style cornerstone cannot.
What it actually buys the issuer — and what it costs
A large, locked-up, disclosed commitment does real work for a deal: it de-risks the book for the underwriters, gives late-arriving institutional buyers a reference point ("Nvidia is in at this price and can't sell for six months"), and can be the difference between a deal that clears and one that gets pulled. That's part of why SB Energy leaned on it after its roadshow drew pushback on valuation in September — a locked-up $3 billion from Nvidia is a harder signal to ignore than a verbal expression of interest.
The cost is dilution of that signal's meaning when the commitment isn't actually binding, and a real cost to the company when it is: a prepaid forward at a 10% discount is capital raised more cheaply than the headline valuation implies. Reading the difference between "has indicated interest" (TRex Bio's Lilly language), "has committed" (SB Energy's Nvidia placement), and "is weighing" (Anthropic's Nvidia reporting, as of this writing) is the whole exercise — the words in the S-1 carry the legal weight, and press paraphrase often doesn't. The greenshoe mechanics that stabilize a stock in its first 30 days work on the same principle: a specific, disclosed, contractually bound party absorbing risk that would otherwise sit with ordinary buyers on day one.